1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Flow Cytometry Market
4. Market Overview
4.1. Introduction
4.1.1. Technology Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Flow Cytometry Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Technology/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Flow Cytometry Market Analysis and Forecast, by Technology
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technology, 2017–2031
6.3.1. Cell-based
6.3.2. Bead-based
6.4. Market Attractiveness, by Technology
7. Global Flow Cytometry Market Analysis and Forecast, by Products & Services
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Products & Services, 2017–2031
7.3.1. Reagents & Consumables
7.3.2. Flow Cytometry Instruments
7.3.2.1. Cell Analyzers
7.3.2.2. Cell Sorters
7.3.3. Software
7.3.4. Services
7.3.5. 7.4 Market Attractiveness, by Products & Services
8. Global Flow Cytometry Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Pharmaceutical & Drug Discovery
8.3.2. Diagnostics
8.3.3. Others
8.4. Market Attractiveness, by Application
9. Global Flow Cytometry Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals & Diagnostic Labs
9.3.2. Academic & Research Institutions
9.3.3. Others
9.4. Market Attractiveness, by End-user
10. Global Flow Cytometry Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Flow Cytometry Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Technology, 2017–2031
11.2.1. Cell-based
11.2.2. Bead-based
11.3. Market Attractiveness, by Technology
11.4. Market Value Forecast, by Products & Services, 2017–2031
11.4.1. Reagents & Consumables
11.4.2. Flow Cytometry Instruments
11.4.2.1. Cell Analyzers
11.4.2.2. Cell Sorters
11.4.3. Software
11.4.4. Services
11.5. Market Attractiveness, by Products & Services
11.6. Market Value Forecast, by Application, 2017–2031
11.6.1. Pharmaceutical & Drug Discovery
11.6.2. Diagnostics
11.6.3. Others
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Hospitals & Diagnostic Labs
11.8.2. Academic & Research Institutions
11.8.3. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Technology
11.11.2. By Products & Services
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Flow Cytometry Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Technology, 2017–2031
12.2.1. Cell-based
12.2.2. Bead-based
12.3. Market Attractiveness, by Technology
12.4. Market Value Forecast, by Products & Services, 2017–2031
12.4.1. Reagents & Consumables
12.4.2. Flow Cytometry Instruments
12.4.2.1. Cell Analyzers
12.4.2.2. Cell Sorters
12.4.3. Software
12.4.4. Services
12.5. Market Attractiveness, by Products & Services
12.6. Market Value Forecast, by Application, 2017–2031
12.6.1. Pharmaceutical & Drug Discovery
12.6.2. Diagnostics
12.6.3. Others
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Hospitals & Diagnostic Labs
12.8.2. Academic & Research Institutions
12.8.3. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Technology
12.11.2. By Products & Services
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Flow Cytometry Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Technology, 2017–2031
13.2.1. Cell-based
13.2.2. Bead-based
13.3. Market Attractiveness, by Technology
13.4. Market Value Forecast, by Products & Services, 2017–2031
13.4.1. Reagents & Consumables
13.4.2. Flow Cytometry Instruments
13.4.2.1. Cell Analyzers
13.4.2.2. Cell Sorters
13.4.3. Software
13.4.4. Services
13.5. Market Attractiveness, by Products & Services
13.6. Market Value Forecast, by Application, 2017–2031
13.6.1. Pharmaceutical & Drug Discovery
13.6.2. Diagnostics
13.6.3. Others
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Hospitals & Diagnostic Labs
13.8.2. Academic & Research Institutions
13.8.3. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Technology
13.11.2. By Products & Services
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Flow Cytometry Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Technology, 2017–2031
14.2.1. Cell-based
14.2.2. Bead-based
14.3. Market Attractiveness, by Technology
14.4. Market Value Forecast, by Products & Services, 2017–2031
14.4.1. Reagents & Consumables
14.4.2. Flow Cytometry Instruments
14.4.2.1. Cell Analyzers
14.4.2.2. Cell Sorters
14.4.3. Software
14.4.4. Services
14.5. Market Attractiveness, by Products & Services
14.6. Market Value Forecast, by Application, 2017–2031
14.6.1. Pharmaceutical & Drug Discovery
14.6.2. Diagnostics
14.6.3. Others
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Hospitals & Diagnostic Labs
14.8.2. Academic & Research Institutions
14.8.3. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Technology
14.11.2. By Products & Services
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Flow Cytometry Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Technology, 2017–2031
15.2.1. Cell-based
15.2.2. Bead-based
15.3. Market Attractiveness, by Technology
15.4. Market Value Forecast, by Products & Services, 2017–2031
15.4.1. Reagents & Consumables
15.4.2. Flow Cytometry Instruments
15.4.2.1. Cell Analyzers
15.4.2.2. Cell Sorters
15.4.3. Software
15.4.4. Services
15.5. Market Attractiveness, by Products & Services
15.6. Market Value Forecast, by Application, 2017–2031
15.6.1. Pharmaceutical & Drug Discovery
15.6.2. Diagnostics
15.6.3. Others
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Hospitals & Diagnostic Labs
15.8.2. Academic & Research Institutions
15.8.3. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Technology
15.11.2. By Products & Services
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Becton, Dickinson and Company
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Merck & Co., Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Beckman Coulter, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Sysmex Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Abbott
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Miltenyi Biotec
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Bio-Techne
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Agilent Technologies, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Bio-Rad Laboratories, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Thermo Fisher Scientific
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
